CAT No: CP25306
CAS No: 1315449-95-6
Synonyms/Alias: 1315449-95-6;Fmoc-Alpha-Me-Orn(Boc)-OH;Fmoc-alpha-me-l-orn(boc)-oh;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid;(2S)-5-{[(tert-butoxy)carbonyl]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpentanoic acid;MFCD17019257;(2S)-5-([(TERT-BUTOXY)CARBONYL]AMINO)-2-(([(9H-FLUOREN-9-YL)METHOXY]CARBONYL)AMINO)-2-METHYLPENTANOIC ACID;Fmoc-(Me)Orn(Boc)-OH;Fmoc-beta-Me-Orn(Boc)-OH;SCHEMBL15893672;AKOS030212534;AS-58652;(S)-Na-Fmoc-NW-Boc-alpha-Methylornithine;CS-0357472;D97207;S-1315449-95-6;
Chemical Name: (S)-N-alpha-(9-Fluorenylmethyloxycarbonyl)-C-alpha-methyl-N-delta-t-butyloxycarbonyl-ornithine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C26H32N2O6 |
M.W/Mr. | 468.5 |
Sequence | Three Letter Code:Fmoc-aMeOrn(Boc)(Boc)-OH |
Application | Nucleotides synthesis; drug screening |
Size | 1 g;5 g; |
InChI | InChI=1S/C26H32N2O6/c1-25(2,3)34-23(31)27-15-9-14-26(4,22(29)30)28-24(32)33-16-21-19-12-7-5-10-17(19)18-11-6-8-13-20(18)21/h5-8,10-13,21H,9,14-16H2,1-4H3,(H,27,31)(H,28,32)(H,29,30)/t26-/m0/s1 |
InChI Key | HUGFTODLQPYAOF-SANMLTNESA-N |
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.